Back
Bio-Rad Laboratories, Inc. (BIO)
Life Sciences Tools & ServicesBIO · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$297.28
+4.73%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$27.85
ROE
2.5%
Gross margin
52.0%
Debt/Equity
0.20x
Revenue growth
1.1%
Bio-Rad Laboratories, Inc. — company intelligence
Earnings surprises
Q1 2026$1.89 vs $2.00 est-5.7%
Q4 2025$2.51 vs $2.73 est-8.0%
Q3 2025$2.26 vs $1.95 est+15.7%
Q2 2025$2.61 vs $1.75 est+49.1%
Insider activity · 90 days
4 buys3 sellsnet +429 shares
ENGELHARDT EVA ANETTESell 550 · May 11, 2026
Lakkaraju Roop Kalyanother 1,078 · Apr 24, 2026
ENLOE COURTNEY Cother 186 · Apr 24, 2026
Recent SEC filings
4 — Insider transaction reportMay 13, 2026
8-K — Material event reportApr 30, 2026
10-Q — Quarterly reportApr 30, 2026
Latest news
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential — SeekingAlpha · 1w ago
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? — Yahoo · 2w ago
Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas — Yahoo · Jun 4, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Bio-Rad Laboratories, Inc.
Weekly undervalued picks (like BIO)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.